Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 3Not yet recruiting 2

Sponsor Class

OTHER 5

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Breast 1

Conditions

Neoplasms 1Lung Neoplasms 1Hypoactive Delirium 1Cancer Diagnosis 1Breast Neoplasms 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Health Personnel × Clear all
NCT05837039 2026-03-04

A Comparison of Healthcare Provider and Caregiver Perception of Discomfort in Advanced Cancer Patients Who Have a Hypoactive Delirium

M.D. Anderson Cancer Center

Recruiting
100 enrolled

Hypoactive Delirium

NCT07416513 2026-02-18

ALTHEA

European Institute of Oncology

Phase NA Recruiting
200 enrolled

Cancer Diagnosis

NCT06762496 2025-11-28

A New Tool to Promote Patient's Engagement in Their Healthcare Process

European Institute of Oncology

Recruiting
180 enrolled
Breast

Breast Neoplasms

NCT06965608 2025-05-11

FLACC-Brazil

Hospital Israelita Albert Einstein

Phase NA Not yet recruiting
1,200 enrolled
Tumor-Agnostic

Neoplasms

NCT06592430 2024-09-19

The Impact of Communication With Healthcare Providers Via WeChat on Survival Outcomes for Lung Cancer Patietns

Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting
2,000 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡